Home/Filings/4/0001104659-22-064786
4//SEC Filing

Drutz David 4

Accession 0001104659-22-064786

CIK 0001326190other

Filed

May 24, 8:00 PM ET

Accepted

May 25, 7:00 PM ET

Size

14.5 KB

Accession

0001104659-22-064786

Insider Transaction Report

Form 4
Period: 2022-05-24
Drutz David
Director
Transactions
  • Purchase

    Common Stock, par value $0.0001

    2022-05-24$4.50/sh+1,200$5,40019,012 total
Holdings
  • Common Stock, par value $0.0001

    (indirect: See Footnote)
    333
Footnotes (1)
  • [F1]Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeother

Related Parties

1
  • filerCIK 0001428764

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 7:00 PM ET
Size
14.5 KB